Abceutics, Inc.—a preclinical-stage biopharmaceutical company spun out of UB researcher Joseph Balthasar's lab—has been acquired by the global biopharmaceutical company Merck. Abceutics is working to improve the safety and efficacy of an important emerging class of cancer drugs.
The Power of Partnerships